Open AccessAbstract 2791: mTOR inhibitor and VEGFR inhibitor combination therapy regress a doxorubicin resistant osteosarcoma in a patient-derived orthotopic xenograft model and in vivo angiogenesis assay model
Author(s) -
Hiromichi Oshiro,
Yasunori Tome,
Robert M. Hoffman,
Kotaro Nishida
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-2791
Subject(s) - angiogenesis , in vivo , medicine , doxorubicin , angiogenesis inhibitor , cancer research , pazopanib , everolimus , nude mouse , pharmacology , cancer , sunitinib , chemotherapy , oncology , biology , microbiology and biotechnology